Risk of Postpartum Hemorrhage in Hypertensive Disorders of Pregnancy: Stratified by Severity
- 2 April 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (15) , 2165-2174
Abstract
Objective We aimed to determine the composite maternal hemorrhagic outcome (CMHO) among individuals with and without hypertensive disorders of pregnancy (HDP), stratified by disease severity. Additionally, we investigated the composite neonatal adverse outcome (CNAO) among individuals with HDP who had postpartum hemorrhage (PPH) versus did not have PPH. Study Design Our retrospective cohort study included all singletons who delivered at a Level IV center over two consecutive years. The primary outcome was the rate of CMHO, defined as blood loss ≥1,000 mL, use of uterotonics, mechanical tamponade, surgical techniques for atony, transfusion, venous thromboembolism, intensive care unit admission, hysterectomy, or maternal death. A subgroup analysis was performed to investigate the primary outcome stratified by (1) chronic hypertension, (2) gestational hypertension and preeclampsia without severe features, and (3) preeclampsia with severe features. A multivariable regression analysis was performed to investigate the association of HDP with and without PPH on a CNAO which included APGAR 6 hours, hypoxic–ischemic encephalopathy, or neonatal death. Results Of 8,357 singletons, 2,827 (34%) had HDP. Preterm delivery <37 weeks, induction of labor, prolonged oxytocin use, and magnesium sulfate usage were more common in those with versus without HDP (p < 0.001). CMHO was higher among individuals with HDP than those without HDP (26 vs. 19%; adjusted relative risk [aRR] = 1.11, 95% CI: 1.01–1.22). In the subgroup analysis, only individuals with preeclampsia with severe features were associated with higher CMHO (n = 802; aRR = 1.52, 95% CI: 1.32–1.75). There was a higher likelihood of CNAO in individuals with both HDP and PPH compared to those with HDP without PPH (aRR = 1.49, 95% CI: 1.06–2.09). Conclusion CMHO was higher among those with HDP. After stratification, only those with preeclampsia with severe features had an increased risk of CMHO. Among individuals with HDP, those who also had a PPH had worse neonatal outcomes than those without hemorrhage. Key PointsKeywords
This publication has 46 references indexed in Scilit:
- Association of adverse outcomes with three-tiered risk assessment tool for obstetrical hemorrhageAmerican Journal of Obstetrics & Gynecology MFM, 2023
- Correlation between hemorrhage risk prediction score and severe maternal morbidityAmerican Journal of Obstetrics & Gynecology MFM, 2021
- Reduction of severe maternal morbidity from hemorrhage using a state perinatal quality collaborativeAmerican Journal of Obstetrics and Gynecology, 2017
- Academic Medical Centers and Community Hospitals Integration: Trends and StrategiesJournal of the American College of Radiology, 2017
- Global causes of maternal death: a WHO systematic analysisThe Lancet Global Health, 2014
- Incidence, risk factors, and temporal trends in severe postpartum hemorrhageAmerican Journal of Obstetrics and Gynecology, 2013
- Estimating risk factors for development of preeclampsia in teen mothersArchives of Gynecology and Obstetrics, 2012
- Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestationAmerican Journal of Obstetrics and Gynecology, 2007
- Increased postpartum hemorrhage rates in AustraliaInternational Journal of Gynecology & Obstetrics, 2007
- Chronic hypertension and the risk for adverse pregnancy outcome after superimposed pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 2004